Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurphy, Declan-
dc.contributor.otherRisbridger, Gail-
dc.contributor.otherBristow, Robert-
dc.contributor.otherSandhu, Shahneen-
dc.date2017-01-
dc.date.accessioned2017-05-03T01:56:05Z-
dc.date.available2017-05-03T01:56:05Z-
dc.date.issued2017-05-
dc.identifier.citationEur Urol. 2017 May;71(5):748-749en_US
dc.identifier.issn0302-2838en_US
dc.identifier.urihttp://hdl.handle.net/11434/1053-
dc.description.abstractEditorial refers to: Rong Na, S. Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M. Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L. Helseth Jr, Margo Quinn, Elizabeth Humphries, Kathleen E. Wiley, Sarah D. Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi-Hsiung Wang, Janardan Khandekar, et al. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. European Urology, Volume 71, Issue 5, May 2017, Pages 740-747.en_US
dc.publisherElsevieren_US
dc.subjectProstate Canceren_US
dc.subjectMolecular Differentionen_US
dc.subjectIndolent Canceren_US
dc.subjectAgressive Canceren_US
dc.subjectClinicopathologicen_US
dc.subjectProstate-Specific Antigenen_US
dc.subjectPSAen_US
dc.subjectRepair Gene Defectsen_US
dc.subjectTriage Patientsen_US
dc.subjectLethal Prostate Canceren_US
dc.subjectUrologyen_US
dc.subjectAustralian Prostate Cancer Research Centre Epworth HealthCare, Victoria, Australiaen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleThe Evolving Narrative of DNA Repair Gene Defects: Distinguishing Indolent from Lethal Prostate Cancer.en_US
dc.typeLetteren_US
dc.rights.holderElsevieren_US
dc.identifier.doi10.1016/j.eururo.2017.01.025en_US
dc.identifier.journaltitleEuropean Urologyen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/28131466en_US
dc.description.affiliatesDivision of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.en_US
dc.description.affiliatesThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.en_US
dc.description.affiliatesProstate Cancer Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.en_US
dc.description.affiliatesMonash Partners Comprehensive Cancer Consortium and Cancer Program Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.en_US
dc.description.affiliatesPrincess Margaret Cancer Centre/University Health Network, Toronto, Canada; Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Canada.en_US
dc.description.affiliatesDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.en_US
dc.type.studyortrialReviewen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
Epworth Prostate Centre
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.